Clinical Trial Update: Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updating results for myelofibrosis treated with pacritinib prior to allogeneic stem cell transplantation (HOVON134MF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Myelofibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING